Another ligand fishing for G protein-coupled receptor 14. Discovery of urotensin II-related peptide in the rat brain

Peptides

Volumn 29, Issue 5, 2008, Pages 809-812

  Sugo, Tsukasa ^a   Mori, Masaaki ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

GPR14; SENR; Urotensin II; Urotensin II related peptide; URP; UTR

Indexed keywords

G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 14; UNCLASSIFIED DRUG; UROTENSIN II; UROTENSIN II RELATED PEPTIDE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; DNA SEQUENCE; GENE EXPRESSION; HUMAN; IMMUNOREACTIVITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; SPINAL CORD;

AMINO ACID SEQUENCE; ANIMALS; ANXIETY; BRAIN; HUMANS; LIGANDS; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE HORMONES; PROTEIN PRECURSORS; RATS; RECEPTORS, G-PROTEIN-COUPLED; SEQUENCE ALIGNMENT; UROTENSINS;

MAMMALIA; RATTUS; SUS; TELEOSTEI;

EID: 42049094825     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.06.005     Document Type: Article

References (32)

1. Ames R.S., Sarau H.M., Chambers J.K., Willette R.N., Aiyar N.V., Romanic A.M., et al. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401 (1999) 282-286
2. Bern H.A., and Lederis K. A reference preparation for the study of active substances in the caudal neurosecretory system of teleosts. J Endocrinol 45 (1969) xi-xii
3. Bottrill F.E., Douglas S.A., Hiley C.R., and White R. Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries. Br J Pharmacol 130 (2000) 1865-1870
4. Chartrel N., Leprince J., Dujardin C., Chatenet D., Tollemer H., Baroncini M., et al. Biochemical characterization and immunohistochemical localization of urotensin II in the human brainstem and spinal cord. J Neurochem 91 (2004) 110-118
5. Chartrel N., Conlon J.M., Collin F., Braun B., Waugh D., Vallarino M., et al. Urotensin II in the central nervous system of the frog Rana ridibunda: immunohistochemical localization and biochemical characterization. J Comp Neurol 364 (1996) 324-339
6. Conlon J.M., O'Harte F., Smith D.D., Tonon M.C., and Vaudry H. Isolation and primary structure of urotensin II from the brain of a tetrapod, the frog Rana ridibunda. Biochem Biophys Res Commun 188 (1992) 578-583
7. Conlon J.M., Yano K., Waugh D., and Hazon N. Distribution and molecular forms of urotensin II and its role in cardiovascular regulation in vertebrates. J Exp Zool 275 (1996) 226-238
8. Coulouarn Y., Lihrmann I., Jegou S., Anouar Y., Tostivint H., Beauvillain J.C., et al. Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc Natl Acad Sci 95 (1998) 15803-15808
9. Coulouarn Y., Jegou S., Tostivint H., Vaudry H., and Lihrmann I. Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. FEBS Lett 457 (1999) 28-32
10. Do-Rego J.C., Chatenet D., Orta M.H., Naudin B., Le Cudennec C., Leprince J., et al. Behavioral effects of urotensin-II centrally administered in mice. Psychopharmacology (Berl) 183 (2005) 103-117
11. Dunn A.J., and Berrige C.W. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?. Brain Res Rev 15 (1990) 71-100
12. Dun S.L., Brailoiu G.C., Yang J., Chang J.K., and Dun N.J. Urotensin II immunoreactivity in the brainstem and spinal cord of the rat. Neurosci Lett 305 (2001) 9-12
13. Egginger J.G., and Calas A. A novel hypothalamic neuroendocrine peptide: URP (urotensin-II-related peptide)?. C R Biol 328 (2005) 724-731
14. Gartlon J., Parker F., Harrison D.C., Douglas S.A., Ashmeade T.E., Riley G.J., et al. Central effects of urotensin-II following ICV administration in rats. Psychopharmacology 155 (2001) 426-433
15. Gibson A., Wallace P., and Bern H.A. Cardiovascular effects of urotensin II in anesthetized and pithed rats. Gen Comp Endocrinol 64 (1986) 435-439
16. Gibson A. Complex effects of Gillichthys urotensin II on rat aortic strips. Br J Pharmacol 91 (1987) 205-212
17. Hasegawa K., Kobayashi Y., and Kobayashi H. Vasodepressor effects of urotensin II in rats. Neuroendocrinol Lett 14 (1992) 357-363
18. Itoh H., Itoh Y., Rivier J., and Lederis K. Contraction of major artery segments of rat by fish neuropeptide urotensin II. Am J Physiol 252 (1987) R361-R366
19. Katano Y., Ishihata A., Aita T., Ogaki T., and Horie T. Vasodilator effect of urotensin II, one of the most potent vasoconstricting factors, on rat coronary arteries. Eur J Pharmacol 402 (2000) R5-R7
20. Liu Q., Pong S.S., Zeng Z., Zhang Q., Howard A.D., Williams Jr. D.L., et al. Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem Biophys Res Commun 266 (1999) 174-178
21. Matsumoto Y., Abe M., Watanabe T., Adachi Y., Yano T., Takahashi H., et al. Intracerebroventricular administration of urotensin II promotes anxiogenic-like behaviors in rodents. Neurosci Lett 358 (2004) 99-102
22. Mori M., Sugo T., Abe M., Shimomura Y., Kurihara M., Kitada C., et al. Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor SENR (GPR14). Biochem Biophys Res Commun 265 (1999) 123-129
23. Nothacker H.P., Wang Z., McNeill A.M., Saito Y., Merten S., O'Dowd B., et al. Identification of the natural ligand of an orphan G protein-coupled receptor involved in the regulation of vasoconstriction. Nat Cell Biol 1 (1999) 383-385
24. Pelletier G., Lihrmann I., and Vaudry H. Role of androgens in the regulation of urotensin II precursor mRNA expression in the rat brainstem and spinal cord. Neuroscience 115 (2002) 525-532
25. Pelletier G., Lihrmann I., Dubessy C., Luu-The V., Vaudry H., and Labrie F. Androgenic down-regulation of urotensin II precursor, urotensin II-related peptide precursor and androgen receptor mRNA in the mouse spinal cord. Neuroscience 132 (2005) 689-696
26. Pellow S., Chopin P., File S.E., and Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Meth 14 (1985) 149-167
27. RodriguezEchandia E.L., Broitman S.T., and Foscolo M.R. Effects of the chronic ingestion of chlorimipramine and desipramine on the hole board response to acute stresses in male rats. Pharmacol Biochem Behav 26 (1987) 207-210
28. Seidah N.G., Chretien M., and Day R. The family of subtilisin/kexin like pro-protein and pro-hormone convertases: divergent or shared functions. Biochimie 76 (1994) 197-209
29. Sugo T., Murakami Y., Shimomura Y., Harada M., Abe M., Ishibashi Y., et al. Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain. Biochem Biophys Res Commun 310 (2003) 860-868
30. Takeda H., Tsuji M., and Matsumiya T. Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice. Eur J Pharmacol 350 (1998) 21-29
31. Tostivint H., Joly L., Lihrmann I., Parmentier C., Lebon A., Morisson M., et al. Comparative genomics provides evidence for close evolutionary relationships between the urotensin II and somatostatin gene families. Proc Natl Acad Sci 103 (2006) 2237-2242
32. Yano K., Hicks J.W., Vaudry H., and Conlon J.M. Cardiovascular actions of frog urotensin II in the frog, Rana catesbeiana. Gen Comp Endocrinol 97 (1995) 103-110